A phase 3b, randomized controlled study to evaluate the efficacy and safety of tirzepatide once weekly 5 mg and/or maximum tolerated dose versus placebo for maintenance of body weight reduction in participants who have obesity or overweight with Weight-Related comorbidities (SURMOUNT-MAINTAIN)
NCT ID NCT06047548
Summary
The main purpose of this study is to evaluate the efficacy and safety of tirzepatide for the maintenance of body weight reduction.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alliance for Multispecialty Research, LLC
Norman, Oklahoma, 73069, United States
-
Asha Clinical Research - Munster
Hammond, Indiana, 46324, United States
-
Cahaba Research - Pelham
Pelham, Alabama, 35124, United States
-
Consano Clinical Research, LLC
Shavano Park, Texas, 78231, United States
-
East-West Medical Research Institute
Honolulu, Hawaii, 96814, United States
-
Encompass Clinical Research
Spring Valley, California, 91978, United States
-
Iowa Diabetes and Endocrinology Research Center
West Des Moines, Iowa, 50265, United States
-
L-MARC Research Center
Louisville, Kentucky, 40213, United States
-
New Horizon Research Center
Miami, Florida, 33165, United States
-
Oviedo Medical Research
Oviedo, Florida, 32765, United States
-
Pinnacle Clinical Research
San Antonio, Texas, 78229, United States
-
Prime Health and Wellness/SKYCRNG
Fayette, Mississippi, 39069, United States
-
Rocky Mountain Clinical Research
Idaho Falls, Idaho, 83404, United States
-
Rophe Adult and Pediatric Medicine/SKYCRNG
Union City, Georgia, 30291, United States
-
Southern California Dermatology, Inc.
Santa Ana, California, 92701, United States
-
Southern Endocrinology Associates
Mesquite, Texas, 75149, United States
-
The University of Texas Health Science Center at Houston
Bellaire, Texas, 77401, United States
-
Velocity Clinical Research, Dallas
Dallas, Texas, 75230, United States
-
Velocity Clinical Research, Westlake
Los Angeles, California, 90057, United States
-
WR-Clinsearch, LLC
Chattanooga, Tennessee, 37397, United States
Conditions
Explore the condition pages connected to this study.